HMJ-53A accelerates slow inactivation gating of voltage-gated K+ channels in mouse neuroblastoma N2A cells

Neuropharmacology

Volumn 54, Issue 7, 2008, Pages 1128-1135

  Chao, Chia Chia ^a   Shieh, Jeffrey ^a   Kuo, Sheng Chu ^a   Wu, Bor Tsang ^a   Hour, Mann Jen ^a   Leung, Yuk Man ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

C type inactivation; Electrophysiology; HMJ 53A; Nerve cells; Voltage gated K+ channels

Indexed keywords

HMJ 53A; POTASSIUM CHANNEL STIMULATING AGENT; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CHANNEL GATING; DEPOLARIZATION; MOUSE; NEUROBLASTOMA; NONHUMAN; POTASSIUM CELL LEVEL; POTASSIUM CURRENT; PRIORITY JOURNAL;

ANIMALS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; ION CHANNEL GATING; MEMBRANE POTENTIALS; MICE; NEUROBLASTOMA; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; QUINAZOLINES;

EID: 42749088908     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.03.006     Document Type: Article

References (25)

1. Andalib P., Consiglio J.F., Trapani J.G., and Korn S.J. The external TEA binding site and C-type inactivation in voltage-gated potassium channels. Biophys. J. 87 (2004) 3148-3161
2. Choe S. Potassium channel structures. Nat. Rev. Neurosci. 3 (2002) 115-121
3. Choe S., Kreusch A., and Pfaffinger P.J. Towards the three-dimensional structure of voltage-gated potassium channels. Trends Biochem. Sci. 24 (1999) 345-349
4. + channels. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5092-5095
5. Claydon T.W., Vaid M., Rezazadeh S., Kehl S.J., and Fedida D. 4-aminopyridine prevents the conformational changes associated with p/c-type inactivation in Shaker channels. J. Pharmacol. Exp. Ther. 320 (2007) 162-172
6. Cordero-Morales J.F., Jogini V., Lewis A., Vásquez V., Cortes D.M., Roux B., and Perozo E. Molecular driving forces determining potassium channel slow inactivation. Nat. Struct. Mol. Biol. 14 11 (2007) 1062-1069
7. Fedida D., Maruoka N.D., and Lin S. Modulation of slow inactivation in human cardiac Kv1.5 channels by extra- and intracellular permeant cations. J. Physiol. 515 (1999) 315-329
8. Hille B. Ion Channels of Excitable Membranes (2001), Sinauer press, Sunderland, Mass
9. Hour M.J., Huang L.J., Teng C.M., and Kuo S.C. Synthesis and antiplatelet activity of alkoxy derivatives of 2-phenylquinazolines. Chin. Pharm. J. 52 (2000) 167-177
10. Klemic K.G., Kirsch G.E., and Jones S.W. U-type inactivation of Kv3.1 and Shaker potassium channels. Biophys. J. 81 (2001) 814-826
11. + channels. Am. J. Physiol. 268 (1995) 535-556
12. Kurata H.T., Doerksen K.W., Eldstrom J.R., Rezazadeh S., and Fedida D. Separation of P/C- and U-type inactivation pathways in Kv1.5 potassium channels. J. Physiol. 568 (2005) 31-46
13. Kurata H.T., and Fedida D. A structural interpretation of voltage-gated potassium channel inactivation. Prog. Biophys. Mol. Biol. 92 (2006) 185-208
14. + channels. J. Biol. Chem. 277 (2002) 29045-29053
15. Kurata H.T., Soon G.S., and Fedida D. Altered state dependence of c-type inactivation in the long and short forms of human Kv1.5. J. Gen. Physiol. 118 (2001) 315-332
16. Leung Y.M., Kang Y., Gao X., Xia F., Xie H., Sheu L., Tsuk S., Lotan I., Tsushima R.G., and Gaisano H.Y. Syntaxin 1A binds to the cytoplasmic C terminus of Kv2.1 to regulate channel gating and trafficking. J. Biol. Chem. 278 (2003) 17532-17538
17. + channels in vascular myocytes. J. Pharmacol. Exp. Ther. 290 (1999) 1165-1174
18. López-Barneo J., Hoshi T., Heinemann S.H., and Aldrich R.W. Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. Recept. Channels 1 (1993) 61-71
19. McKay M.C., and Worley III J.F. Linoleic acid both enhances activation and blocks Kv1.5 and Kv2.1 channels by two separate mechanisms. Am. J. Physiol. Cell Physiol. 281 (2001) 1277-1284
20. + channels distinguish between the sites of tetraethylammonium blockade and C-type inactivation. J. Physiol. 499 (1997) 361-367
21. + channels by membrane lipids. Science 304 (2004) 265-270
22. + current in GH3 pituitary cells and its modification by chemical reagents. J. Physiol. 410 (1989) 587-612
23. Rezazadeh S., Claydon T.W., and Fedida D. KN-93 (2-[N-(2-hydroxyethyl)]-N-(4 methoxybenzenesulfonyl)]-amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a calcium/calmodulin-dependent protein kinase II inhibitor, is a direct extracellular blocker of voltage-gated potassium channels. J. Pharmacol. Exp. Ther. 317 (2006) 292-299
24. Wang S., Morales M.J., Qu Y.J., Bett G.C., Strauss H.C., and Rasmusson R.L. Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect. J. Physiol. 546 (2003) 387-401
25. Yellen G. The voltage-gated potassium channels and their relatives. Nature 419 (2002) 35-42